Table 4.
Preclinical studies examining the use of different combinations of MSC-subpopulations and hydrogels for cartilage engineering.
Author | Year | Animal; Defect Type | Cell Source | Hydrogel | Study Design | Results |
---|---|---|---|---|---|---|
Lv et al. [88] | 2018 |
|
ADMSCs | HA hydrogel |
|
|
Feng et al. [89] | 2018 |
|
ADMSCs | HA hydrogels |
|
|
Sevastianov et al. [90] | 2021 |
|
ADMSCs | COL hydrogels |
|
|
Jia et al. [91] | 2019 |
|
Synovial fluid-derived MSCs | CH hydrogels |
|
|
Wu et al. [92] | 2019 |
|
Umbilical cord-derived MSCs | HA hydrogels |
|
|
Li et al., [93] | 2018 |
|
Arthroscopic flushing fluid-derived MSCs | Polypegda/HA hydrogels |
|
|
ADMSCs: adipose-derived mesenchymal stromal cells; CH: chitosan; HA: hyaluronic acid; OA: osteoarthritis.